2017Journal of Crohn s and ColitisOpen access

P104 Rebamipide, sucralfate, and rifaximin have the suppressive effects on radiation-induced inflammation in the intestine of mouse

Won Moon, S.J. Park, J.H. Kim, M.I. Park, S.E. Kim, Kwonil Jung

Open full text 0 citations

Abstract

Background: Radiotherapy for malignant abdominopelvic disease results in radiation-induced enterocolitis. However, there is no well-established preventive strategy. The aim is to evaluate the suppressive effect of rebamipide, sucralfate and rifaximin on ionizing radiation (IR)-induced acute inflammation and apoptosis in the intestine of mouse. Methods: Thirty ICR mice were divided into (1) a vehicle-treated control group before sham IR, (2) a vehicle-treated group before IR, and (3–5) rebamipide, sucralfate or rifaximin-treated groups before IR. The intestine was resected at 4 hours after 4 Gy IR to the abdominopelvis. Pro-/anti-inflammatory and pro-/anti-apoptotic factors were investigated. Results: NAMPT was down-regulated after IR, which was attenuated by rebamipide, sucralfate and rifaximin (p<0.05). Activation of NF-κB and phosphorylation of MAPKs were induced by IR, which were suppressed by rebamipide, sucralfate, and rifaximin (p<0.05). TNF-α, IL-1β, and IL-6 were increased by IR, while attenuated by rebamipide, sucralfate, and rifaximin down to similar level of control group (p<0.05). The iNOS, COX-2 and PGE2 were significantly induced by IR, which were attenuated by rebamipide, sucralfate, and rifaximin (p<0.05). ICAM-1 was corresponded to above mentioned results. [Ca2+] oscillation was increased by IR, which was attenuated by rebamipide, sucralfate, and rifaximin. Proapoptotic gene (Bax, c-Myc) and antiapoptotic gene (Bcl-2, Bcl-xL) expressions were potently suppressed and induced, respectively, by rebamipide, sucralfate, and rifaximin. The release of cytochrome C was increased by IR, while it was attenuated by rebamipide, sucralfate, and rifaximin (p<0.05). Caspase 3 and caspase 7 were also elevated by IR compared to control group, however, they showed decline by rebamipide, sucralfate, and rifaximin (p<0.05). Conclusions: This study demonstrated that rebamipide, sucralfate, and rifaximin have the suppressive effects on IR-induced acute inflammation and apoptosis in the intestine of mouse. Rebamipide, sucralfate, and rifaximin may have beneficial effects in preventing acute radiation-induced enterocolitis.

Open-access reader

About this research paper

What this paper is about

Background: Radiotherapy for malignant abdominopelvic disease results in radiation-induced enterocolitis. However, there is no well-established preventive strategy. The aim is to evaluate the suppressive effect of rebamipide, sucralfate and rifaximin on ionizing radiation (IR)-induced acute inflammation and apoptosis in the intestine of mouse. Methods: Thirty ICR mice were divided into (1) a vehicle-treated control group before sham IR, (2) a vehicle-treated group before IR, and (3–5) rebamipide, sucralfate or rifaximin-treated groups before IR. The intestine was resected at 4 hours after 4 Gy IR to the abdominopelvis. Pro-/anti-inflammatory and pro-/anti-apoptotic factors were investigated. Results: NAMPT was down-regulated after IR, which was attenuated by rebamipide, sucralfate and rifaximin (p<0.05). Activation of NF-κB and phosphorylation of MAPKs were induced by IR, which were suppressed by rebamipide, sucralfate, and rifaximin (p<0.05). TNF-α, IL-1β, and IL-6 were increased by IR, while attenuated by rebamipide, sucralfate, and rifaximin down to similar level of control group (p<0.05). The iNOS, COX-2 and PGE2 were significantly induced by IR, which were attenuated by rebamipide, sucralfate, and rifaximin (p<0.05). ICAM-1 was corresponded to above mentioned results. [Ca2+] oscillation was increased by IR, which was attenuated by rebamipide, sucralfate, and rifaximin. Proapoptotic gene (Bax, c-Myc) and antiapoptotic gene (Bcl-2, Bcl-xL) expressions were potently suppressed and induced, respectively, by rebamipide, sucralfate, and rifaximin. The release of cytochrome C was increased by IR, while it was attenuated by rebamipide, sucralfate, and rifaximin (p<0.05). Caspase 3 and caspase 7 were also elevated by IR compared to control group, however, they showed decline by rebamipide, sucralfate, and rifaximin (p<0.05). Conclusions: This study demonstrated that rebamipide, sucralfate, and rifaximin have the suppressive effects on IR-induced acute inflammation and apoptosis in the intestine of mouse. Rebamipide, sucralfate, and rifaximin may have beneficial effects in preventing acute radiation-induced enterocolitis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Background: Radiotherapy for malignant abdominopelvic disease results in radiation-induced enterocolitis. However, there is no well-established preventive strategy. The aim is to evaluate the suppressive effect of rebamipide, sucralfate and rifaximin on ionizing radiation (IR)-induced acute inflammation and apoptosis in the intestine of mouse. Methods: Thirty ICR mice were divided into (1) a vehicle-treated control group before sham IR, (2) a vehicle-treated group before IR, and (3–5) rebamipide, sucralfate or rifaximin-treated groups before IR. The intestine was resected at 4 hours after 4 Gy IR to the abdominopelvis. Pro-/anti-inflammatory and pro-/anti-apoptotic factors were investigated. Results: NAMPT was down-regulated after IR, which was attenuated by rebamipide, sucralfate and rifaximin (p<0.05). Activation of NF-κB and phosphorylation of MAPKs were induced by IR, which were suppressed by rebamipide, sucralfate, and rifaximin (p<0.05). TNF-α, IL-1β, and IL-6 were increased by IR, while attenuated by rebamipide, sucralfate, and rifaximin down to similar level of control group (p<0.05). The iNOS, COX-2 and PGE2 were significantly induced by IR, which were attenuated by rebamipide, sucralfate, and rifaximin (p<0.05). ICAM-1 was corresponded to above mentioned results. [Ca2+] oscillation was increased by IR, which was attenuated by rebamipide, sucralfate, and rifaximin. Proapoptotic gene (Bax, c-Myc) and antiapoptotic gene (Bcl-2, Bcl-xL) expressions were potently suppressed and induced, respectively, by rebamipide, sucralfate, and rifaximin. The release of cytochrome C was increased by IR, while it was attenuated by rebamipide, sucralfate, and rifaximin (p<0.05). Caspase 3 and caspase 7 were also elevated by IR compared to control group, however, they showed decline by rebamipide, sucralfate, and rifaximin (p<0.05). Conclusions: This study demonstrated that rebamipide, sucralfate, and rifaximin have the suppressive effects on IR-induced acute inflammation and apoptosis in the intestine of mouse. Rebamipide, sucralfate, and rifaximin may have beneficial effects in preventing acute radiation-induced enterocolitis.

Key concepts: Rebamipide, Sucralfate, Rifaximin, Gastroenterology, Apoptosis, Internal medicine, Medicine, Pharmacology

Related papers

Back to paper searchBrowse research topicsOriginal source
P104 Rebamipide, sucralfate, and rifaximin have the suppressive effects on radiation-induced inflammation in the intestine of mouse — Research Paper | ScholarLens